Type I Interferon Regulates the Placental Inflammatory Response to Bacteria and is Targeted by Virus: Mechanism of Polymicrobial Infection-Induced Preterm Birth

American Journal of Reproductive Immunology

Volumn 75, Issue 4, 2016, Pages 451-460

  Racicot, Karen ^a,b   Kwon, Ja Young ^a,c   Aldo, Paulomi ^a   Abrahams, Vikki ^a   El Guindy, Ayman ^a   Romero, Roberto ^d   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Yonsei University College of Medicine   (South Korea)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bacteria; Infection; Interferon; Polymicrobial; Pregnancy; Trophoblast; Virus

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; STAT3 PROTEIN; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL1B PROTEIN, MOUSE; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; INFLAMMATION; INTRAUTERINE INFECTION; MICROARRAY ANALYSIS; MIXED INFECTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TROPHOBLAST; VIRUS INFECTION; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; PATHOLOGY; PHOSPHORYLATION; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; TRANSFORMED CELL LINE; VIROLOGY;

ANIMALS; CELL LINE, TRANSFORMED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-BETA; INTERLEUKIN-1BETA; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; RECEPTOR, INTERFERON ALPHA-BETA; STAT3 TRANSCRIPTION FACTOR; TROPHOBLASTS; VIRUS DISEASES;

EID: 84975775490     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12501     Document Type: Article

References (47)

1. Iams JD, Romero R, Culhane JF, Goldenberg RL: Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008; 371:164-175.
2. Romero R, Dey SK, Fisher SJ: Preterm labor: one syndrome, many causes. Science 2014; 345:760-765.
3. Simmons LE, Rubens CE, Darmstadt GL, Gravett MG: Preventing preterm birth and neonatal mortality: exploring the epidemiology, causes, and interventions. Semin Perinatol 2010; 34:408-415.
4. Rubens CE, Sadovsky Y, Muglia L, Gravett M, Lackritz E, Gravett C: Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med 2014; 6:262sr265.
5. Muglia L, Katz M: The enigma of spontaneous preterm birth. N Engl J Med 2010; 362:529-535.
6. Lawn J, Kinney M: Preterm birth: now the leading cause of child death worldwide. Sci Transl Med 2014; 6:263ed221.
7. Goldenberg RL, Culhane JF, Iams JD, Romero R: Epidemiology and causes of preterm birth. Lancet 2008; 371:75-84.
8. Dimes Mo, PMNCH, Children S, WHO: Preterm birth matters. In Born Too Soon: The Global Action Report, C Howson, M Kinney, J Lawn (eds). Geneva, Switzerland, WHO, 2012, pp 1-8.
9. Romero R, Chaiworapongsa T, Espinoza J: Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr 2003; 133:1668S-1673S.
10. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS: The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007; 50:652-683.
11. Pacora P, Chaiworapongsa T, Maymon E, Kim Y, Gomez R, Yoon BH, Ghezzi F, Berry S, Qureshi F, Jacques S, Kim J, Kadar N, Romero R: Funitis and chorionic vasculitis-the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002; 11:18-25.
12. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK: The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000; 183:1124-1129.
13. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi J-H, Han TR: Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182:675-681.
14. Yoon BH, Jun J, Romero R, Park K, Gomez R, Choi J-H, Kim I-O: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-l[3, and tumor necrosis factor-s), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177:19-26.
15. Villar J, Papageorghiou AT, Pang R, Ohuma EO, Ismail LC, Barros FC, Lambert A, Carvalho M, Jaffer YA, Bertino E, Gravett MG, Altman DG, Purwar M, Frederick IO, Noble JA, Victora CG, Bhutta ZA, Kennedy SH: The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study. Lancet Diabetes Endocrinol 2014; 2:781-792.
16. Romero R, Gomez R, Chaiworapongsa T, Conoscenti G, Kim J, Kim Y: The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001; 15:41-56.
17. Takahashi T, Tanaka M, Brannan C, Jenkins N, Copeland N, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by point mutation in the Fas ligand. Cell 1994; 76:969-976.
18. Cardenas I, Mor G, Aldo P, Lang SM, Stabach P, Sharp A, Romero R, Mazaki-Tovi S, Gervasi M, Means RE: Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol 2011; 65:110-117.
19. Cardenas I, Means RE, Aldo P, Koga K, Lang SM, Booth CJ, Manzur A, Oyarzun E, Romero R, Mor G: Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 2010; 185:1248-1257.
20. Fisher S, Genbacev O, Maidji E, Pereira AC: Human CMV infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 2000; 74:6808-6820.
21. Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, Parry S: Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod 2008; 23:709-715.
22. Reddy U, Zlatnik M, Baschat A, Towbin J, Harman C, Weiner C: Detection of viral deoxyribonucleic acid in amniotic fluid: predictor of abnormal pregnancy. Fetal Diagn Ther 2005; 20:203-207.
23. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S: The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25:21-39.
24. McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A: Type I interferons in infectious disease. Nat Rev Immunol 2015; 15:87-103.
25. Odorizzi PM, Wherry EJ: Immunology. An interferon paradox. Science 2013; 340:155-156.
26. Trinchieri G: Type I interferon: friend or foe? J Exp Med 2010; 207:2053-2063.
27. Edwards MR, Slater L, Johnston SL: Signalling pathways mediating type I interferon gene expression. Microbes Infect 2007; 9:1245-1251.
28. Kovarik P, Sauer I, Schaljo B: Molecular mechanisms of the anti-inflammatory functions of interferons. Immunobiology 2007; 212:895-901.
29. Garcia-Sastre A: Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 2001; 279:375-384.
30. Haller O, Kochs G, Weber F: The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006; 344:119-130.
31. Katze MG, He Y, Gale M Jr: Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2:675-687.
32. Johnson KP, Panitch HS: Interferon therapy for multiple sclerosis. Md Med J 1992; 41:601-603.
33. Racicot K, Cardenas I, Wunsche V, Aldo P, Guller S, Means RE, Romero R, Mor G: Viral infection of the pregnant cervix predisposes to ascending bacterial infection. J Immunol 2013; 191:934-941.
34. Maeyer E, Maeyer-Guignard J, Vandeputte M: Inhibition of interferon of delayed type hypersensitivity in the mouse. PNAS 1975; 72:1753-1757.
35. Mahieu T, Libert C: Should we inhibit type I interferons in sepsis? Infect Immun 2007; 75:22-29.
36. Lee J, Rachmilewitz D, Raz E: Homeostatic effects of TLR9 signaling in experimental colitis. Ann N Y Acad Sci 2006; 1072:351-355.
37. Agrawal H, Jacob N, Carreras E, Bajana S, Putterman C, Turner S, Neas B, Mathian A, Koss MN, Stohl W, Kovats S, Jacob CO: Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol 2009; 183:6021-6029.
38. Ho HH, Ivashkiv LB: Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem 2006; 281:14111-14118.
39. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G: TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007; 131:1124-1136.
40. Ivashkiv LB, Donlin LT: Regulation of type I interferon responses. Nat Rev Immunol 2014; 14:36-49.
41. Luu K, Greenhill CJ, Majoros A, Decker T, Jenkins BJ, Mansell A: STAT1 plays a role in TLR signal transduction and inflammatory responses. Immunol Cell Biol 2014; 92:761-769.
42. Miller AM, Wang H, Park O, Horiguchi N, Lafdil F, Mukhopadhyay P, Moh A, Fu XY, Kunos G, Pacher P, Gao B: Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury. Alcohol Clin Exp Res 2010; 34:719-725.
43. Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB: Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006; 203:1891-1901.
44. Bourgeois P, Stoetzel C, Bellemin A, Mattei M, Perrin-Schmitt P: Human h-twist gene is located at 7p21 and encodes a B-HLH [rpteom tjat is 96% similar to its murine M-twist counterpart. Mamm Genome 1996; 7:915-917.
45. Yin G, Chen R, Alvero AB, Fu HH, Holmberg J, Glackin C, Rutherford T, Mor G: TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 2010; 29:3545-3553.
46. Sosic D, Richardson J, Yu K, Ornitz D, Olson EN: Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kB activity. Cell 2003; 112:169-180.
47. Niesner U, Albrecht I, Janke M, Doebis C, Loddenkemper C, Lexberg MH, Eulenburg K, Kreher S, Koeck J, Baumgrass R, Bonhagen K, Kamradt T, Enghard P, Humrich JY, Rutz S, Schulze-Topphoff U, Aktas O, Bartfeld S, Radbruch H, Hegazy AN, Lohning M, Baumgart DC, Duchmann R, Rudwaleit M, Haupl T, Gitelman I, Krenn V, Gruen J, Sieper J, Zeitz M, Wiedenmann B, Zipp F, Hamann A, Janitz M, Scheffold A, Burmester GR, Chang HD, Radbruch A: Autoregulation of Th1-mediated inflammation by twist1. J Exp Med 2008; 205:1889-1901.